Lipid levels in sickle‐cell disease associated with haemolytic severity, vascular dysfunction and pulmonary hypertension

Summary Pulmonary hypertension (PH) in sickle cell disease (SCD) is an emerging and important clinical problem. In a single‐institution adult cohort of 365 patients, we investigated lipid and lipoprotein levels and their relationship to markers of intravascular haemolysis, vascular dysfunction and P...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:British journal of haematology 2010-05, Vol.149 (3), p.436-445
Hauptverfasser: Zorca, Suzana, Freeman, Lita, Hildesheim, Mariana, Allen, Darlene, Remaley, Alan T., Taylor, James G., Kato, Gregory J.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Summary Pulmonary hypertension (PH) in sickle cell disease (SCD) is an emerging and important clinical problem. In a single‐institution adult cohort of 365 patients, we investigated lipid and lipoprotein levels and their relationship to markers of intravascular haemolysis, vascular dysfunction and PH. In agreement with prior studies, we confirm significantly decreased plasma levels of total cholesterol, high‐density lipoprotein‐cholesterol (HDL‐C) and low‐density lipoprotein‐cholesterol (LDL‐C) in SCD versus ethnically‐matched healthy controls. Several cholesterol parameters correlated significantly with markers of anaemia, but not endothelial activation or PH. More importantly, serum triglyceride levels were significantly elevated in SCD compared to controls. Elevated triglyceride levels correlated significantly with markers of haemolysis (lactate dehydrogenase and arginase; both P 
ISSN:0007-1048
1365-2141
1365-2141
DOI:10.1111/j.1365-2141.2010.08109.x